Clinical Trial

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Study acronym: TCCP
Recruiting
View on ClinicalTrials.gov →
Summary
The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-06-04; most recent amendment 2025-05-20.
Trial Details
NCT Number NCT03977402
Lead Sponsor New Mexico Cancer Research Alliance
Collaborators: H. Lee Moffitt Cancer Center and Research Institute, Ohio State University Comprehensive Cancer Center
Conditions Cancer, Cancer Risk
Enrollment 47,500 participants
Start Date 2016-01-27
Primary Completion 2036-12-31 (estimated)
Study Completion 2037-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-22